SHELL ASSET MANAGEMENT CO - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 127 filers reported holding ANI PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$106
-99.9%
2,644
-18.4%
0.01%
+25.0%
Q3 2022$104,000
-14.0%
3,240
-20.6%
0.00%0.0%
Q2 2022$121,000
+6.1%
4,081
+0.3%
0.00%
+33.3%
Q1 2022$114,000
-47.0%
4,069
-12.8%
0.00%
-25.0%
Q4 2021$215,000
+40.5%
4,668
+0.3%
0.00%
+33.3%
Q3 2021$153,000
-9.5%
4,652
-3.5%
0.00%0.0%
Q2 2021$169,000
+2.4%
4,822
+5.7%
0.00%0.0%
Q1 2021$165,0004,5620.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 367,754$10,911,0004.08%
AIGH Capital Management LLC 244,500$7,254,0001.91%
Parkman Healthcare Partners LLC 108,559$3,221,0001.19%
Worth Venture Partners, LLC 60,831$1,927,0001.13%
Global Alpha Capital Management Ltd. 323,731$9,605,0001.04%
Mesirow Financial Investment Management, Inc. 6,892$204,0000.99%
MARATHON CAPITAL MANAGEMENT 74,460$2,209,0000.71%
EMERALD ADVISERS, LLC 455,880$13,526,0000.70%
EMERALD MUTUAL FUND ADVISERS TRUST 356,865$10,588,0000.61%
Jackson Creek Investment Advisors LLC 32,698$1,120,0000.45%
View complete list of ANI PHARMACEUTICALS INC shareholders